About the Company
We do not have any company description for PAVmed Inc. at the moment.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
57
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on PAVmed Inc.
PAVmed Reports Q2 2025 Financial Results and Developments
In its second quarter of 2025, PAVmed Inc. reported significant business developments and financial results. Lucid Diagnostics processed 2,756 EsoGuard tests, generating $1.2 million in revenue, and ...
PAVmed Inc. (PAVM) Q3 2024 Earnings Call Transcript
PAVmed Inc. (NASDAQ:PAVM) Q3 2024 Earnings Call Transcript November 14, 2024 8:30 AM ETCompany ParticipantsMatt Riley - Director of IRLishan Aklog - ...
PAVmed Inc.'s (PAVM) CEO Lishan Aklog on Q1 2022 Results - Earnings ...
PAVmed Inc. (NASDAQ:PAVM) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ETCompany ParticipantsAdrian Miller - VP, IRLishan Aklog - Chairman and ...
PAVmed to Hold a Business Update Conference Call on March 29, 2022
PAVmed to Hold a Business Update Conference Call on March 29, 2022 Company conference call and webcast at 4:30 PM EDT March 08, 2022 08:30 AM Eastern Standard Time ...
PAVmed and Lucid to Hold Joint Business Update Conference Call on ...
PAVmed Inc. is a highly differentiated, multi-product, commercial-stage medical technology company with a diversified product pipeline addressing unmet clinical needs encompassing a broad spectrum ...
PAVmed to Present at The LD 500 Virtual Conference
Contacts: Investors Mike Havrilla Director of Investor Relations (814) 241-4138 JMH@PAVmed.com Media Shaun O'Neil Chief Commercial Officer (518) 812-3087 SMO@PAVmed.com SOURCE: PAVmed, Inc. via LD ...
PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript
PAVmed Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to PAVmed’s Fourth Quarter and ...
PAVmed Inc. Grants Shareholders Lucid Diagnostics Dividend
PAVmed Inc. has announced a significant reward for its shareholders: a special pro rata dividend distribution of roughly 3.3 million shares, constituting 6.9% of Lucid Diagnostics’ common stock.
What Type Of Shareholders Make Up PAVmed Inc.'s (NASDAQ:PAVM) Share ...
Every investor in PAVmed Inc. (NASDAQ:PAVM) should be aware of the most powerful shareholder groups. Large companies usually have institutions as shareholders, and we usually see insiders owning ...
PAVmed Inc. (PAVM) Upgraded to Strong Buy: Here's What You ... - Nasdaq
PAVmed Inc. (PAVM) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...
Similar Companies
Loading the latest forecasts...